Streptomyces ghanaensis (A T C C 14672) produces the phosphoglycolipid antibiotic moeno mycin consisting of several components. A solid phase extraction procedure was developed which allowed a rapid isolation of both moenomycin and its biosynthetic intermediates from culture filtrates. Semi-preparative high performance liquid chromatography followed by high performance liquid chromatographv-mass spectrometry provided structural data on the dif ferent moenomycin components. In order to obtain initial information on the biosynthetic pathway, moenomycin non-producing mutants were isolated. They were shown to release intermediates with shorter lipid chains suggesting that the lipid chain synthesis probably takes place at a later stage o f the moenomycin biosynthesis. Based on the biological activity and the analytical data, we assume that a modification and in particular a shorter lipid portion drastically influences the inhibitory activity of this antibiotic.
Introduction
Streptomycetes are interesting from a biological and pharmacological point of view in that they synthesize an unusually complex range o f second ary metabolites exhibiting antibiotic activity. More than half of such compounds known today includ ing most of the medically and agriculturally impor tant ones are of streptomycete origin. Various Streptomycetes sps. namely S. ghanaensis. S.
With cell free systems from Escherichia coli it was demonstrated that the antibiotic moenomycin A selectively inhibits the transglycosylation step by its inhibitory effect on the penicillin binding pro tein PBP lb (van Heijenoort et al., 1992) . PBPs catalyse both transglycosylation and transpeptidation, the two last biosynthetic reactions needed for the production of crosslinked peptidoglvcan from the membrane intermediate GlcNAc-MurNAc-(pentapeptide)-PP-undecaprenol. The structural resemblance between moenomycin and the disac charide phospholipid carrier intermediate led to the speculation that moenomycin A functions as a competitive inhibitor of this enzyme. Van H eije noort et al. (1992) demonstrated that an antibiotically active derivative of moenomycin A forms a reversible complex with the enzyme. By analysing the transglycosylation inhibition properties of both moenomycin degradation products (Welzel. 1993 , Scherkenbeck et al., 1993 . Marzian et al., 1994 as well as of synthetic compounds (Lüning et al., 1994) it has been shown that the units E-F-G -H -I (Table I) tion available concerning the biosynthesis of the moenomycins. In this publication we describe the isolation of S. ghanaensis mutants, the develop ment of a solid phase extraction method to obtain moenomycin components from the wildtype and biosynthetic intermediates from the mutants, and a HPLC-M S analysis of the moenomycin compo nents. Furthermore, we performed structure activ ity studies in order to get an idea o f the biosyn thetic process.
Materials and M ethods

Apparatus and chemicals
Fine chemicals, TLC-plates, H PLC columns, H P L C solvents and Adsorbex reversed phase 18 (RP-18) columns were obtained from (E. Merck, Darmstadt, Germany); yeast extract, tryptone and agar from Unipath (Wesel, Germany); beef extract and antibiotic medium no.l from Difco (Norder stedt, Germany). Moenomycin standard, moeno mycin A degradation product MC and genapol were kindly provided by Hoechst AG. The U V mutagenesis was carried out using a Spectroline ENF-26/F lamp. H PLC was performed using a LK B Bromma (Freiburg, Germany) H PL C system consisting o f a 2157 autosampler cum injector, 2249 gradient pump and a 2151 variable wave length monitor with a 2221 integrator. In addition a 2140 diode array detector equipped with a per sonal computer and LKB wavelength EG software was used. A triple-quadrupole mass spectrometer A P I III (Sciex, Thornhill, Ontario, Canada) equ ipped with a nebulizer-assisted electrospray ion source was also used.
M icroorganism s S.
ghanaensis A TC C 14672 wildtype strain pro ducing moenomycin and its UV-mutants 3, 32, and 1146 isolated within this work were used for char acterization purposes. Staphylococcus aureus p209 (strain collection, Hoechst A G ) was used as the sensitive Gram positive test organism.
U V mutagenesis
The wildtype S. ghanaensis was cultivated on sporulation agar plates at 30 °C for 7-10 days. The green spores were scraped o ff and suspended in sterile water. A 10 ml suspension with a titre of 4.55 x 108/ml was then subjected to U V light (254 nm) and samples were taken after different time intervals (0, 3, 5, 7, 10, 12, 15, 17, 20, 25 and 30 min) . After a serial dilution till 10-4 they were plated on sporulation agar plates and incubated at 30 °C. The sporulation medium contained sucrose 3 g, dextrin 15 g, NaCl 0.5 g, M gC l2 0.5 g, K H 2P 0 4 0.5 g, tryptone 5 g, beef extract 1 g and agar 23 g in 1 liter tap water.
Isolation o f stable n o n -p ro d u cin g mutants
Colonies appearing on selected sporulation agar plates (= 0.7% survival rate after U V mutagene sis) were transferred onto sporulation agar plugs in sterile petri plates and incubated further at 30 °C for 7-10 days. These were then placed on test agar plates seeded with Staph, aureus and in cubated overnight at 37 °C. The test agar con tained 30.5 g antibiotic medium no.l in 1 liter tap water. Staph, aureus was cultivated in Luria broth, overnight, at 37 °C. This medium consisted o f tryp tone 10 g, yeast extract 5 g, NaCl 0.5 g, glucose 1 g, tap water 1 liter. The cells were centrifuged and the pellet washed twice and resuspended in sterile normal saline. A difference in the type and size of the inhibition zones led to the selection of desired mutant colonies for further analysis.
C o feeding tests
Stable mutants were grown in parallel, on spor ulation agar plates, two at a time, with a gap of about 2 mm. These plates were then incubated at 30 °C. After 10 days, agar strips, each carrying 2 mutants were placed on bioassay plates containing Staph, aureus for detecting a cofeeding reaction if any. These strains were also simultaneously cocul tivated pairwise in shake flasks for 10 days at 30 °C for the same purpose.
T L C
Pre-coated high performance T L C (H P T L C ) RP-18 plates (silica gel, 0.25 mm) were cut into 1 cm strips and spotted with a 3 [.il moenomycin solution (1 mg/ml in 20 m M potassium phosphate buffer, pH 7.2) and eluted in different solvent combinations (Table II) . Detection was by char ring at 110 °C after spraying with 5% H 2S 0 4 in absolute EtOH.
A c id extraction
The extraction was carried out as described by Lindner et al. (1961) .
Solid phase extraction (S P X )
Adsorbex RP-18 columns (100 mg) were used for selective sample enrichment. The columns were activated with each 2 ml of isopropanol, M eO H and 20 mM potassium phosphate buffer, pH 7.2. Then 10 ml o f centrifuged culture supernatants were applied, followed by a wash using 2 ml of the same phosphate buffer, 1 ml acetonitrile and 2 ml isopropanol. Selective elution was done with 2 ml of a 50:50 acetonitrile: phosphate buffer mixture. The eluate was vacuum dried and dis solved in 100 [Al phosphate buffer. For this purpose the wildtype and the mutants were cultivated for 10 days at 30 °C in 30 ml sporulation media con taining 0.5% genapol. The mycelia were addition ally homogenised manually together with the cul ture fluid and centrifuged at 11,000 x g for 30 min. 10 ml supernatant were used for SPX.
H P L C
Analytical H PLC was performed using a LiChroCart 250-4 H PLC cartridge (Superspher-100, RP-18 endcapped). Phosphate buffer was pre pared by dissolving 10 mg K H 2P 0 4 in 1 1 deminer alised water and adjusted to pH 7.8 with K 2H P 0 4. H P L C grade M eO H , acetonitrile plus phosphate buffer (35:25:40 v/v) were degassed with helium and comprised the mobile phase. The flow rate of the mobile phase was 0.4 ml/min. In addition to a U V detector, a diode array detector was em ployed. For detection purposes, a wave-length range between 180-300 nm was used. The lipid portion of the moenomycins absorbs strongly be low 220 nm due to the presence of double bonds, and the U V chromophore at 258 nm. Semi-preparative H PLC was carried out by injecting 60 |il of an 1 mg/ml moenomycin standard solution into a Lichrosorb R P -18 column (7 [im, 250 x 10 i.d.) and sepa ration was performed at a flow rate o f 3 ml/min. The mobile phase contained phosphate buffer (pH 7.8), M eO H and acetonitrile (40:35:25 v/v). Detection wavelength was 258 nm. The separated moeno mycin fractions were dried in vacuo and then dis solved in a small volume of phosphate buffer.
Fractions isolated by semi-preparative H PLC were analysed by HPLC-M S on a Nucleosil C-18 column (5 (im, 100 x 2 i.d.) with a linear gradient elution within 10 min from solvent A (0.09% TFA/ acetonitrile) to solvent B ( 0.1% T F A ) at a flow rate of 200 ^1/min. Electrospray mass spectra were recorded on-line with a triple-quadrupole mass spectrometer equipped with a nebulizer assisted electrospray (= ion spray) source.
Results
A nalysis o f the m oen om ycin production pattern o f the wildtype Streptom yces ghanaensis ( A T C C 14672) using solid phase extraction, H P L C and H P L C -M S
In order to analyse the biosynthesis of an antibi otic, techniques are required for a rapid and reliable isolation and structure determination o f biosyn thetic intermediates. We therefore developed a solid phase extraction (SP X ) protocol for the isola tion o f moenomycin and moenomycin-like pro ducts from culture broths. The hydrophobic RP-18 material was chosen as column material since the lipid portion of moenomycin binds effectively to this matrix in polar solutions, (e.g in buffer) and un bound matter can be simply washed off. RP-18 coated T L C plates were used in a preliminarily way to test the mobility of moenomycin in different solvent systems (Table II) . The method was opti mised using a moenomycin standard. Using this method, substance recovery after extraction was nearly 100%. With this technique, it was possible to remove constituents o f the sporulation medium ef fectively. The established method is sensitive (only 10 ml sample required), specific and reproducible. The culture eluates of the wildtype S. ghanaensis obtained after acid extraction and SPX were sepa rated on a RP-18 H PLC column and compared to a 1 mg/ml standard moenomycin solution (Fig. 1) . The SPX eluate showed the characteristic elution time (m in) Fig. 1 . H PLC profiles of a moenomycin standard solu tion (A ), moenomycin extracts obtained after acid ex traction (B ) and solid phase extraction (S P X ) (C). In each chromatogram U V detection was at 258 nm and the detector sensitivity was 0.02 absorbance units for full scale deflection (ALJFS). Profile B corresponds to 200 ml and profile C to 10 ml extracted volume.
profile for the moenomycins (Fig. 1C) as in the case of the standard (Fig. 1A) . In the case o f the acidic extraction sample, the moenomycin peaks were very small (Fig. IB ) . A diode array detector was used, which allowed several wavelengths to be scanned simultaneously and to obtain a U V spectrum of every single detected peak. Using a diode array detector it was found that the moeno mycin components A !2, Q , A , C3 and C4 absorb both at 258 and below 220 nm and therefore pos sess both the U V chromophor and the lipid portion.
For a more detailed analysis, the moenomycin components were first separated by semi-prepara tive H PLC ( Fig. 2A) , and then the fractions were analysed using HPLC-MS. Since the separation of the components by semi-preparative H PLC was not as good as on an analytical column, only 3 different fractions were collected. These were then checked with an analytical H PLC column in order to determine their purity, and compared with a moenomycin standard. It was found that fraction 1 contained moenomycin A 12 and minor amounts of the moenomycins Q , A and C3 (Fig. 2B) . Frac tion 2 consisted of a mixture of moenomycin A and C3 and fraction 3 contained moenomycin C4 (Figs. 2C and 2D ). These fractions were investi gated by HPLC-MS. The individual components of the purified fractions were clearly separated under the selected conditions (Fig. 3) . The electrospray mass spectra obtained by HPLC-MS showed the (M + H )+ ions of the different moenomycin compo nents. Fraction 2 was separated on the nucleosil C-18 column into two components with retention times o f 8.2 and 8.5 min (Fig. 3A1) . The mass spectrum of the first signal had its main mass peak at m /z 1582 (Fig. 3A2 ) and this result correlated well with that of moenomycin A , which was deter mined as m /z 1581.7 (Fehlhaber et al., 1990) . Inter estingly, an additional signal was detected at m /z 1599, which was assigned to a (M + N H 4) + ion ob served also in the case of the other moenomycin components. The component eluting at 8.5 min corresponds to moenomycin C3 and showed a mo lecular mass peak at m /z 1404 (Fig. 3A3) .
The HPLC-M S analysis of fraction 3 showed that beside moenomycin C4 it still contained traces of moenomycin A (Fig. 3C1) . The T IC showed several peaks. The main mass signal at m /z 1420 belongs to moenomycin C4 (Fig. 3C2) . As pre viously stated, moenomycin A 12 ( Figure 2B ) could only be partially separated. Two major signals at 8.9 and 9.1 min were seen in the total ion chroma togram (Fig. 3B1) . The fraction eluting at 8.9 min consisted of two compounds with (M + H )+ ions at m /z 1582 and 1568, respectively (Fig. 3B2) . The former as already quoted, corresponds to moeno mycin A and the latter to moenomycin A 12. The mass difference o f only 14 showed that the two components are very similar in their structure. The major compound eluting after 9.1 min showed a protonated molecular ion at m /z 1390. It has the greatest mass difference of 192 with respect to moenomycin A and represents moenomycin Q (Fig. 3B3) . After determining the moenomycin production pattern of the wildtype it was possible to take a closer look at the biosynthesis of this an tibiotic. 
Isolation and analysis o f m oen om ycin biosynthesis mutants
To obtain information on the biosynthesis of moenomycin and the part of the molecule relevant for biological activity, mutants of S. ghanaensis were isolated which were blocked in moenomycin biosynthetic steps. Therefore S. ghanaensis was ir radiated by UV. A survival rate of 0.1 % -l % which has been proven to be optimal for the isolation of mutants with single phenotypical mutations (Hopwood, 1970 ) was achieved after 20-30 min of irra diation in the case of S. ghanaensis. A fter U V mutagenesis, 16,043 potential mutant colonies were screened for antibiotic production. 83 of them showed inhibition zones different to that of the wildtype strain, which produced a very clear zone. 57 mutants produced clear, but tiny, 2 turbid and 24 null mutants absolutely no inhibition zones. This bioassay procedure was repeated sev eral times using both plate and shake flask cul tures of the mutants and they proved to be stable. The null-mutants and those with turbid zones were then subjected to cofeeding experiments. H ow ever, none of the mutant combinations lead to a wildtype zone of clearance.
Cultures of three selected mutants were sub jected to SPX and the samples were analysed with HPLC. The detection was carried out at 258 nm, specific for the U V chromophore. The mutants 3, 32 (both produced turbid inhibition zones) and 1146 (produced no inhibition zone) showed the presence of new signals in their H PLC profiles (Figs. 4B, 4C and 4D ). These mutant products eluted earlier than the components of the moeno mycin standard (Fig. 4 A ) and are therefore more hydrophilic. However the main products synthe sized by the mutants 3, 32 and 1146 (Figs. 4B, 4C and 4D) showed longer retention times than the reference substance MC. MC is an enzymatic de gradation product of moenomycin A containing only the oligosaccharide and the chromophore (Metten et al., 1992) . Since M C lacks the moenocinol portion it is very hydrophilic, indicated by a short retention time in the H PLC system (Table III) .
The U V spectra of the major, novel compounds synthesized by the mutant strains obtained after diode array detection revealed similar absorbance characteristics like those of the wildtype moeno mycins (data not shown). The great similarity but also the definite differences between these spectra indicated that the mutant peaks originated from the moenomycin pathway.
Discussion
Structural evaluation o f the m oen om ycin s p ro d u ce d by S. ghanaensis ( A T C C 14672)
The biosynthesis of moenomycin is supposed to be very complex, since this antibiotic is not one single, chemically well defined end product, but composed o f structurally similar components (Huber, 1979 ; Heßler-Klintz et al., 1993; Scherkenbeck et al., 1993; Donnerstag et al., 1995). It was therefore initially important to develop methods for analysing the production spectrum of S. g h a naensis, which could then provide a basis, for studying the biosynthetic pathway of this antibi otic. An acidic extraction procedure was employed initially for the isolation of moenomycin from cul ture extracts (Lindner et al., 1961) . This method required a large amount (200 ml) of culture fluid and was very insensitive. Furthermore, moeno mycin biosynthetic intermediates labile at lower PH levels would have disintegrated during this process. Especially the allyl ether bond in moeno mycin is sensitive to acids (Marzian et al., 1994, and references therein). Therefore, we developed a solid phase extraction (SP X ) protocol. This method was optimised using RP-18 T L C plates for the specific isolation of moenomycin and its inter mediates. The optimization of the widely applied SPX, using the same adsorbent on T L C plates and SPX columns turned out to be highly efficient. The appropriate solvent system determined by T L C was then used with RP-18 columns. The extraction proved to be very sensitive and reproducible. It removed disturbing impurities and thus facilitated H PLC analysis. Also, the partial antibiotic activity of the mutants 3 and 32. showing turbid inhibition zones, remained intact after this extraction. To our knowledge none of the literature on SPX to date has applied this simple but very useful time-and material-saving step employing RP-18 T L C plates.
On the basis of degradation and spectroscopic studies a structure for moenomycin was proposed (Welzel et al., 1981) ; this was confirmed by 13C N M R and fast atom bombardment mass spectrom etry (FAB -M S) data (Welzel et al., 1983) . A struc tural revision after a detailed FAB-MS analysis combined with N M R and chemical results was made. This demonstrated that unit F contained a second nitrogen function, a carboxamide group in stead o f the carboxylic acid (Fehlhaber et al., 1990) ( Table I ). Using the semi-preparative RP-18 H PLC column, in combination with an analytical RP-18 column from a different manufacturer, a separation of all the moenomycins was possible. The exact reproduction of the published moeno mycin A molecular mass which is 1581.7 (Fehl haber et al., 1990) was used here as a positive, in ternal control. The spectrum of moenomycin C3 showed a mass peak at m /z 1404 making a mass difference of 178 between moenomycin A and C3. Since the U V chromophore is still present in moe nomycin C3 as shown by H PLC -D AD , it is prob able that the glucose unit D (Table I ) is missing.
The mass peak at m /z 1420, corresponding to moenomycin C4, shows a difference of 16 from that o f moenomycin C3; this correlates with a sin gle oxygen atom (Fig. 3C2) . These results indicate the proposed structures for moenomycin C3 and C4 based on FAB-MS and 13C N M R methods, af ter chemical degradation of moenomycin C3 (Scherkenbeck et al., 1993) . The structure for moe nomycin C4 has not been proved rigorously by this means.
Component A 12 appeared at m /z 1568 ( Fig. 3B2 ) and this slight difference of 14 u from moenomycin A suggested that the two compo nents are structurally very similar, with the differ ence due to the lack of a methyl group. This corre lated with the structure proposal for moenomycin A 12 (Donnerstag et al., 1995) . Most likely the sub stance eluting at 9.2 min is moenomycin Q . The observed mass difference from that of moeno-mycin A (Fig. 3B3 ) is in agreement with a struc ture in which both a glucose (-178) and a methyl group (-14) are absent. This is plausible, since moenomycin C3 lacks a glucose molecule and moenomycin A 12 a methyl group. Our results are based on a semi-preparative H PLC separation of the moenomycin components obtained after SPX from the wildtype, and subsequent HPLC-MS analyses.
Structural requirem ents f o r the antibiotic activity o f m o e n o m y c in determ ined by S. ghanaensis mutants
Biosynthetic pathways of secondary metabolites can be understood much better with the help of mutants blocked at different stages. For example, different antibiotic biosynthetic pathways could be proposed after analysing a set o f null mutants as in the case o f bialaphos (Murakami et al., 1986) . However, no cofeeding was observed in the case o f the isolated S. ghanaensis null mutants. This may be due to minute amounts o f cosynthesis pro ducts, which are insufficient for the total inhibition of Staph, aureus and the subsequent production of clear inhibition zones. Another more likely possi bility may be the lack of, or difficulty in, interme diate uptake between the mutants.
In order to elucidate the biosynthetic pathway, further analyses of the mutant products using bio chemical methods were necessary. None of the an alysed mutants produced the moenomycins A 12, Cj, A + C 3 and C4. The mutants 3, 32 and 1146 syn thesized more hydrophilic compounds with shorter retention times than those of the moeno mycin components, but longer than that o f the moenomycin A degradation product MC (Ta ble III). The amount of the compounds secreted by the mutants was very small so that it was not possible to isolate enough material to carry out a H PLC-M S analysis.
The wild-type S. ghanaensis (A T C C 14672) re leases moenomycin with the completely intact lipid chain. This can then bind to the transglycosidase of Staph, aureus p209 (van Heijenoort et al., 1992), resulting in the formation o f clear zones o f inhibition. The mutants 3 and 32 produce moeno mycin intermediates which are more hydrophilic than the moenomycin components, owing to the shorter retention times in the H PLC column. One may speculate that these mutants have turbid zones of inhibition because the shorter lipid chains of their intermediates cannot retain the transglycosidase; this probably means that the binding effi ciency has been reduced and only a partial inhibi tion of the test organism is possible. The mutant 1146 synthesizes an intermediate, which is rather hydrophilic, but more hydrophobic than MC; which contains only the U V chromophore and the sugar portion of moenomycin A. This mutant pro duct perhaps has a too short lipid chain to be able to bind properly to the transglycosidase and func tion as a competitive inhibitor. It shows no inhibi tion zones in the bio-assay. The C25 lipid chain (moenocinol) is composed o f 3 isoprene units, and the central C 10 part (C-5 through C-22) does not obey the isoprene rule (Böttger and Welzel, 1983) . It is most probable that the mutants 3 and 32 are involved much earlier in the biosynthesis of the lipid chain than the mutant 1146. Since all these intermediates still possess the U V chromophore, which is bound to the last sugar moiety, the sugar portion with perhaps the exception of the branched glucose (unit D, Table I ) may be still present and unchanged. These data suggest that the length of the synthesized lipid portion is ex tremely important for the antibiotic activity of the mutant intermediates. The data obtained after mu tant analyses, did not establish whether moenoci nol is attached as a complete unit to the moeno mycin oligosaccharide, or less likely whether the lipid part is subsequently synthesized on the at tached sugar part.
The essential, functionally important parts of the moenomycin molecule are the units E-F-G-H-I (Fehlhaber et al., 1990) presented in Table I . R e moval or oxidation of the lipid unit of moeno mycin A lead to a total loss of antibiotic activity (Marzian et al., 1994) , whereas saturation o f all the double bonds in the lipid part of moenomycin A and the deletion of the sugar portion (Welzel et al., 1987 , Fehlhaber et al., 1990 did not affect its antibiotic activity. The lipid chain has to perhaps insert itself in the membrane of the damaged bacterium, in order to compete with the C55-lipid carrier. Differences in the in vivo activity against Staph, aureus and the in vitro inhibition of the transglycosylase were noticed. Whereas the hexahydroxy compound obtained after the oxida tion o f moenomycin A was inactive both in vivo and in vitro, the tetrahydroxy-moenomycin A de rivative was inactive in v ivo but showed high activ ity in the in vitro test systems. This observation seems to indicate that a non-polar lipid part is nec essary for the attachment of the antibiotic to the cytoplasmic membrane of the test organisms. In the case of the in vitro systems, the enzyme active site may be more directly accessible. Furthermore, a degradation product of moenomycin A obtained after the removal o f both the lipid and the Chro mophore part exhibited distinct activity in an in vitro test system but it was inactive in v ivo (Marzian et al., 1994) . Based on these data it seemed likely that the major intermediates from the mu tants 3 and 32 have incomplete lipid parts, are therefore more polar and cannot attach strongly to the cytoplasmic membrane of Staph, aureus. This would lead to only a partial inhibition o f the test organism. The intermediate from the mutant 1146, which probably has a very short lipid chain, was very polar. This could account for its failure to at tach to the cytoplasmic membrane and thus pro duced no inhibition zones. Based on the biological activity and the analytical data, we assume that a modification and in particular a shorter lipid por tion, drastically influences the inhibitory activity of moenomycin.
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